Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
2.
J Med Screen ; 9(3): 104-8, 2002.
Article in English | MEDLINE | ID: mdl-12370320

ABSTRACT

OBJECTIVES: To investigate socioeconomic variation in participation in flexible sigmoidoscopy (FS) screening for colorectal cancer. DESIGN: A prospective study nested within a multicentre randomised controlled trial of the efficacy of FS screening for the prevention and early detection of colorectal cancer (the UK flexible sigmoidoscopy trial). SETTING: Glasgow, Scotland. PARTICIPANTS: 55-64 year old adults, registered with general practitioners participating in the FS trial. MAIN OUTCOME MEASURES: Screening participation measured at three levels: questionnaire return; interest in screening; attendance at screening. RESULTS: Socioeconomic deprivation was a strong predictor of participation. Return of the screening questionnaire, expression of interest in screening, and attendance at the test, were all lower in more deprived groups. CONCLUSIONS: These results highlight the need to consider ways to reduce inequalities in screening uptake, in parallel with the introduction of any new screening programmes, to avoid exacerbating social gradients in cancer mortality.


Subject(s)
Colorectal Neoplasms/prevention & control , Mass Screening/statistics & numerical data , Patient Acceptance of Health Care/statistics & numerical data , Patient Participation/statistics & numerical data , Sigmoidoscopy/statistics & numerical data , Aged , Colorectal Neoplasms/diagnosis , Female , Humans , Middle Aged , Practice Patterns, Physicians'/statistics & numerical data , Prospective Studies , Scotland , Social Class , Socioeconomic Factors , Surveys and Questionnaires
3.
Am J Prev Med ; 21(2): 132-7, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11457633

ABSTRACT

BACKGROUND: Studies have shown that screening reduces colorectal cancer mortality. We analyzed national survey data to determine rates of use of fecal occult blood testing (FOBT) and sigmoidoscopy, and to determine if these rates differ by demographic factors and other health behaviors. METHODS: A total of 52,754 respondents aged >or=50 years were questioned in the 1997 Behavioral Risk Factor Surveillance System (BRFSS) survey (a random-digit-dialing telephone survey of the non-institutionalized U.S. population) about their use of FOBT and sigmoidoscopy. RESULTS: The age-adjusted proportion of respondents who reported having had a colorectal cancer screening test during the recommended time interval (past year for FOBT and past 5 years for sigmoidoscopy) was 19.8% for FOBT, 30.5% for sigmoidoscopy, and 41.1% for either FOBT or sigmoidoscopy. Rates of use of colorectal cancer screening tests were higher for those who had other screening tests (mammography, Papanicolaou smear, and cholesterol check). There were also differences in rates of use of colorectal cancer screening tests according to other health behaviors (smoking, seat belt use, fruit and vegetable intake, and physical activity) and several demographic factors. However, none of the subgroups that we examined reported a rate of FOBT use above 29% within the past year or a rate of sigmoidoscopy use above 41% within the past 5 years. CONCLUSIONS: While rates of use of FOBT and sigmoidoscopy were higher among people who practiced other healthy behaviors, rates of use were still quite low in all subgroups. There is a need for increased awareness of the importance of colorectal cancer screening.


Subject(s)
Colorectal Neoplasms/prevention & control , Health Behavior , Occult Blood , Sigmoidoscopy/statistics & numerical data , Aged , Aged, 80 and over , Female , Health Surveys , Humans , Male , Middle Aged , Statistics as Topic
4.
Am J Med ; 111(8): 643-53, 2001 Dec 01.
Article in English | MEDLINE | ID: mdl-11755508

ABSTRACT

BACKGROUND: Sigmoidoscopy screening, which can dramatically reduce colorectal cancer mortality, is supported increasingly by physicians and payers, and is likely to be performed more frequently in the future. As more physicians and nonphysician medical personnel learn how to perform this procedure, and with attention to quality standards, the overall impact of sigmoidoscopy screening may improve. This review describes elements that characterize high-quality examinations and identifies resources for in-depth information on performing flexible sigmoidoscopy. METHODS: The domains of quality were identified from textbooks, articles, and the professional opinions of gastroenterologists and primary care physicians. Information was obtained from MEDLINE, bibliographies in recent articles, medical professional organizations, equipment manufacturers' representatives, and focus groups of primary care physicians. RESULTS: Nine domains of quality are identified and discussed: training, logistical start-up, patient interaction, bowel preparation, examination technique, lesion recognition, complications, reporting, and processing (equipment cleaning and disinfection). CONCLUSIONS: Persons learning how to perform and to implement flexible sigmoidoscopy may use this information to help ensure the quality of screening examinations.


Subject(s)
Colorectal Neoplasms/pathology , Primary Health Care , Quality of Health Care , Sigmoidoscopy , Humans , Physician-Patient Relations , Sigmoidoscopes
5.
Am J Prev Med ; 19(3): 149-54, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11020590

ABSTRACT

OBJECTIVE: Although recent screening guidelines recommend annual fecal occult blood testing (FOBT) for adults aged > or = 50, a number of studies report that these tests are underused. Systematic efforts to increase awareness of colorectal cancer (CRC) and to promote screening participation are needed to meet national objectives for CRC control. METHODS: This study examined CRC-screening practices and evaluated factors related to recent participation in screening by FOBT in a sample of women aged 50 to 80 who were surveyed about their use of clinical preventive services at Group Health Cooperative, a managed care organization in western Washington State. RESULTS: Of the 931 women eligible for analysis, 75% reported ever having been screened by FOBT and 48% reported having been screened within 2 years before the survey. Participation in screening did not vary by demographic characteristics or by perceived or actual risk of CRC. Women with a positive attitudes toward CRC screening had sevenfold greater odds of recent screening by FOBT (odds ratio=7.1; 95% confidence interval, 4.4 to 11.6). Only 58% of study women reported that their physicians encouraged CRC screening, but this factor was strongly related to participation (odds ratio=12.7; 95% confidence interval, 6.6 to 24.4). CONCLUSIONS: We identified several areas in which understanding of CRC risk may be low. As a whole, these findings suggest that effective strategies to control CRC may include efforts to improve knowledge of risk and prevention, but must also appeal directly to primary care physicians to identify and address their barriers to screening recommendations.


Subject(s)
Colorectal Neoplasms/prevention & control , Occult Blood , Age Factors , Aged , Aged, 80 and over , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/epidemiology , Female , Humans , Mass Screening , Middle Aged , Physician's Role , Primary Health Care , Primary Prevention , Risk Factors
7.
Front Health Serv Manage ; 17(2): 31-5; discussion 51-4, 2000.
Article in English | MEDLINE | ID: mdl-11195777

ABSTRACT

While it is difficult to find two people who agree on the definition of complementary medicine, the McGrady and Freshley and Carlson articles help substantially in creating a common definition. This information should help to move providers and practitioners to a better understanding of complementary medicine and its inevitable presence on the American healthcare scene. In the post-Balanced Budget Act era, healthcare executives and physicians recognize that a business-as-usual approach to the delivery of healthcare services is not an option. Cultivating new sources of revenue and having a retail rather than a reimbursement mindset of new ventures is essential. The $13.7 billion dollars being spent annually on complementary medicine is money hospitals can no longer afford to leave on the table. If complementary medicine is approached with the proper philosophical and leadership commitment, and is truly accepted as an important component in the continuum of care, financial success will follow.


Subject(s)
Complementary Therapies , Continuity of Patient Care , Attitude of Health Personnel , Diffusion of Innovation , Humans , Insurance Coverage , Physicians/psychology , United States
8.
Soc Secur Bull ; 63(3): 26-33, 2000.
Article in English | MEDLINE | ID: mdl-11439703

ABSTRACT

Three programs known collectively as the Medicare buy-in programs are available to pay Medicare Part B premiums and, in some cases, other medical expenses for certain low-income individuals. The Health Care Financing Administration administers those programs, with most functions performed by the states. The Social Security Administration (SSA) plays an indirect role in the buy-in programs: with certain exceptions, people who qualify for Medicare and hence for buy-in are beneficiaries of Social Security retirement or disability programs. SSA is often cited as an agency that might be able to increase enrollment in the buy-in programs through outreach to its beneficiaries and by acting as an intermediary in the enrollment process. The three buy-in programs have different requirements for eligibility. The Qualified Medicare Beneficiary (QMB) program includes individuals who have Part A Medicare benefits and whose income does not exceed 100 percent of federal poverty guidelines. People in the Specified Low-Income Medicare Beneficiary (SLMB) program are individuals who would otherwise be QMBs but whose income is more than 100 percent but less than 120 percent of poverty guidelines. People in the Qualified Individual (QI) program are those who meet the other criteria but whose income is less than 175 percent of poverty guidelines. Various reports and studies by government agencies and advocacy organizations conclude that the buy-in programs are not reaching many of the people who are eligible. Low enrollment appears to be a particular issue for the SLMB and QI programs. States have tried various outreach efforts, but the effectiveness of those efforts has not been adequately assessed. In 1998, Congress mandated that SSA conduct a demonstration project to determine how to increase participation in the buy-in programs. The project tested six different administrative models in which outreach letters were sent to potential beneficiaries asking them to contact SSA and then be screened for eligibility and referred for enrollment. SSA was able to screen about 7.1 percent of letter recipients for buy-in eligibility: 4.2 percent were potentially eligible for the programs based on income and resources, and 3.7 percent enrolled in a buy-in program. An evaluation of the probability that letter recipients would contact SSA to be screened found that: Among the elderly, older individuals were less likely to be screened but more likely to enroll. Among the disabled, older individuals were more likely to be screened but less likely to enroll. The disabled were less likely to be screened but more likely to enroll. Individuals with higher Social Security benefits were more likely to be screened but less likely to enroll. Women were more likely to be screened and to enroll. Being married did not appear to affect screening but negatively affected enrollment. Individuals with a preference for materials in Spanish were much more likely to be screened and enrolled. In some of the demonstration sites, enrollment in a Medicare+Choice plan increased the probability of being both screened and enrolled. SSA conducted a survey of some people who did not respond to the outreach letter. Most of those from whom explanations of the nonresponse were obtained had not responded because they were not eligible on the basis of their income or resources. If SSA were to reproduce the demonstrations in a nationwide outreach effort, a national mailing would include nearly 20 million individuals. If response rates were similar to those seen in the 1999 demonstrations, outreach would produce over 740,000 new buy-in enrollees. That number might be increased modestly by conducting additional outreach efforts in conjunction with the mailing.


Subject(s)
Eligibility Determination/methods , Medicare Part B/organization & administration , Patient Selection , Poverty/economics , Social Security/organization & administration , Centers for Medicare and Medicaid Services, U.S. , Humans , Models, Organizational , Patient Advocacy , Surveys and Questionnaires , United States
9.
Am J Epidemiol ; 150(6): 617-21, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10490001

ABSTRACT

Screening guidelines for colorectal cancer recommend annual fecal occult blood (FOB) testing for adults aged 50 years and older. Self-reported history of screening is frequently the sole source of data available to researchers and clinicians. This study validated FOB testing in a sample of 1,021 older women. Testing rates based on self-reported data exceeded rates based on computerized laboratory records by 13.9%. Agreement was moderate (kappa = 0.52; 95% confidence interval 0.47, 0.58). Sensitivity was 0.92 and specificity 0.58. Logistic regression analysis showed that older age and physician encouragement for FOB testing were associated with accurate recall (p<0.05). Self-report is the most commonly available information about the occurrence and timing of cancer detection procedures. These data suggest cautious use of self-reported screening by FOB for clinical decision making and for research and surveillance.


Subject(s)
Colorectal Neoplasms/prevention & control , Mass Screening/statistics & numerical data , Occult Blood , Aged , Attitude to Health , Female , Health Maintenance Organizations , Humans , Logistic Models , Medical Audit/statistics & numerical data , Mental Recall , Middle Aged , Predictive Value of Tests , Self Care , Sensitivity and Specificity , Washington/epidemiology
10.
AJR Am J Roentgenol ; 172(2): 339-42, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9930778

ABSTRACT

OBJECTIVE: Many benign breast lesions revealed by mammography show features indicating that the lesions have a high, but not complete, likelihood of being benign. The Breast Imaging Reporting and Data System (BI-RADS) allows radiologists to classify these mammograms as "probably benign finding-short interval follow-up suggested" (category 3). We explored whether certain factors are associated with the use of category 3 in a national cancer detection program. MATERIALS AND METHODS: We analyzed data from the National Breast and Cervical Cancer Early Detection Program, a comprehensive nationwide program that provides cancer screening for low-income and medically underserved women. The study population included all women at least 40 years old who had undergone mammography on or before September 30, 1996 (n = 372,760). RESULTS: Of the 372,760 mammograms, 7.7% were classified as category 3. The probability of receiving a category 3 classification decreased as patients' ages increased. Women who were symptomatic were nearly twice as likely as women who were asymptomatic to receive a category 3 classification, and women whose clinical breast examinations had abnormal findings were more than twice as likely as women with examinations having normal findings to receive a category 3 classification. The percentage of mammograms classified as category 3 by state or tribal organization ranged from 1.4% to 14.0%. CONCLUSION: Several patient variables, including patient symptomatology, were associated with the probability of having a mammogram classified as category 3. One of the most important determinants was where the patient underwent mammography, which suggests that variability exists among radiologists themselves in using this BI-RADS code for "probably benign" mammographic lesions.


Subject(s)
Breast Neoplasms/diagnostic imaging , Mammography/classification , Adult , Aged , Appointments and Schedules , Breast Neoplasms/epidemiology , Female , Follow-Up Studies , Humans , Mammography/statistics & numerical data , Mass Screening/statistics & numerical data , Medical Indigency , Medically Uninsured , Middle Aged , Predictive Value of Tests , Probability , Time Factors , United States/epidemiology
11.
MMWR CDC Surveill Summ ; 48(8): 51-88, 1999 Dec 17.
Article in English | MEDLINE | ID: mdl-10634271

ABSTRACT

PROBLEM/CONDITION: In 1995, a total of 55 million persons aged > or =55 years lived in the United States. The members of this large and growing segment of the population are major consumers of health care. Their access to medical and dental preventive services contributes to their likelihood of healthy later years and influences their long-term impact on the health-care delivery system. REPORTING PERIOD: 1995-1997. DESCRIPTION OF SYSTEMS: This report summarizes data from the National Health Interview Survey (NHIS), the state-based Behavioral Risk Factor Surveillance System (BRFSS), and the Medicare Current Beneficiary Study (MCBS) to describe national, regional, and state-specific patterns of access to and use of preventive services among persons aged > or =55 years. RESULTS: During 1995-1997, approximately 90% of persons aged > or =55 years living in the United States reported having a regular source of health-care services. However, only 75%-80% reported receiving a routine checkup during the preceding 2 years. The estimated percentage of persons who reported not being able to receive medical care because of cost was highest for those aged 55-64 years. Within this age group, the percentage was highest among Hispanics (4%) and persons without a high school diploma. Approximately 11% of Medicare beneficiaries reported delaying care be cause of cost or because they had no particular source of care. Percentage estimates varied according to age, race/ethnicity, and sociodemographic status. Approximately 95% of persons aged > or =55 years reported having their blood pressure checked during the preceding 2 years, but only 85%-88% had received a cholesterol evaluation during the preceding 5 years. The percentage of women receiving breast and cervical cancer screening decreased with increasing age, and the percentage of persons aged > or =55 years who had received some form of screening for colorectal cancer was low approximately 25% for fecal occult blood testing (FOBT) and 45% for endoscopy. State-specific rates of compliance with vaccination recommendations among persons aged > or =65 years were higher for influenza vaccine (range: 54%-74%) than for pneumococcal vaccine (range: 32%-59%), and compliance increased with advancing age. State-specific estimates of the percentage of annual dental visits varied 40%-75%, and 41%-88% of persons aged > or =65 years reported not having dental insurance. INTERPRETATION: Access to medical services among adults living in the United States is greater for persons aged > or =65 years, compared with those aged <65 years, presumably because of Medicare coverage. In contrast, use of dental services decreased, despite increased need for preventive and restorative dental care. Although Medicare covers many medical services for older adults, financial, personal, and physical barriers to both medical and dental care create racial, regional, and sociodemographic disparities in health status and use of health services in the United States. PUBLIC HEALTH ACTION: Continued surveillance of access to and use of health services among older adults (i.e., persons aged > or =65 years), as well as among persons aged 55-64 years, will help health-care providers target underserved groups, make Medicare coverage decisions, and develop public health programs to ensure equitable access to services and improve the health of older adults.


Subject(s)
Geriatrics/statistics & numerical data , Health Services Accessibility , Population Surveillance , Preventive Health Services/statistics & numerical data , Aged , Dental Care , Humans , Mass Screening , Middle Aged , United States/epidemiology , Vaccination
12.
Acta Haematol ; 99(1): 45-8, 1998.
Article in English | MEDLINE | ID: mdl-9490567

ABSTRACT

We describe a patient with HIV-related immune thrombocytopenic purpura with known Mycobacterium avium complex (MAC) infection presenting with intracerebral hemorrhage associated with severe thrombocytopenia who failed splenectomy following unsuccessful trials of corticosteroids and intravenous immunoglobulin. His presplenectomy peripheral blood smear showed Howell-Jolly bodies and microscopic examination of his spleen demonstrated multiple granulomas with numerous acid-fast organisms replacing the normal splenic tissue. We postulate that splenic hypofunction secondary to overwhelming MAC infection contributed to the failure of the thrombocytopenia to promptly respond to splenectomy.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Mycobacterium avium-intracellulare Infection/complications , Purpura, Thrombocytopenic/etiology , Splenic Diseases/etiology , Adult , Humans , Male , Mycobacterium avium Complex
13.
AJR Am J Roentgenol ; 170(1): 97-104, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9423608

ABSTRACT

OBJECTIVE: We describe results from 284,503 mammographic examinations and associated diagnostic workups provided to medically underserved women in an ongoing nationwide breast cancer early detection program. MATERIALS AND METHODS: We report the results of mammographic examinations and diagnostic workups on 230,143 medically underserved women 40 years old or older who underwent at least one mammographic examination from July 1991 through June 1995. Mammograms were obtained in hundreds of mammography and clinical facilities throughout the United States, including community health centers, health department clinics, private practitioners' offices, university based facilities, and mobile mammography units. Our analysis included rates of mammograms with abnormal findings (reported according to the categories of the American College of Radiology Breast Imaging Reporting and Data System), breast cancer detection rates, numbers of diagnostic procedures performed, stage and size distribution of breast cancers, and positive predictive value of mammograms and biopsies with abnormal findings--all presented according to screening round and 10-year age intervals. RESULTS: Mammograms with abnormal findings constituted 5% of mammograms in the first round and 4% in subsequent rounds, both proportions declining by approximately one third from the youngest (40-49 years) to the oldest (70 years and older) age group. Breast cancer detection rates per 1000 mammographic examinations were 5.1 for the first round and 2.0 for subsequent rounds; from the youngest to the oldest age group, the first-round rates doubled and the subsequent-round rates tripled. Early-stage cancers accounted for 54% of first-round cancers and 81% of subsequent-round cancers. Percentage of invasive cancers at least 2 cm in size declined from 51% in the first round to 33% in subsequent rounds: however, we found little change in the proportion of lesions smaller than 1 cm. Positive predictive values declined from 9.5 cancers per 100 mammograms with abnormal findings in the first round to 5.6 cancers per 100 mammograms with abnormal findings in the subsequent rounds. CONCLUSION: A large nationwide breast cancer early detection program conducted through hundreds of diverse facilities has provided results that, although not a statistically representative sample of mammography services, are probably the best available characterization of the current state of breast cancer screening practices as they actually occur in the 1990s in the United States. These results should be useful to clinicians, researchers, and public health personnel in counseling patients, planning new studies, and improving efforts to control breast cancer.


Subject(s)
Breast Neoplasms/prevention & control , Mammography/statistics & numerical data , Mass Screening/methods , Adult , Aged , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/epidemiology , Female , Humans , Mass Screening/statistics & numerical data , Medical Indigency , Medically Uninsured , Middle Aged , Minority Groups , Predictive Value of Tests , Risk Factors , Sensitivity and Specificity , United States/epidemiology , Uterine Cervical Neoplasms/prevention & control
14.
Prev Med ; 26(4): 401-7, 1997.
Article in English | MEDLINE | ID: mdl-9245656

ABSTRACT

BACKGROUND: Sun protection behaviors are recommended to prevent skin cancer, which has increased in incidence. This study measured the prevalence of sun protection behaviors and determined personal characteristics associated with them. METHODS: Data from 10,048 white respondents to the 1992 National Health Interview Survey Cancer Control Supplement were analyzed. Multiple logistic regression models were constructed to relate personal characteristics to specific behaviors. RESULTS: Fifty-three percent of respondents reported they were "very likely" to use sunscreen, wear protective clothing, or seek shade if they were outside on a sunny day for more than 1 hr. Proportions for the individual behaviors were 32, 28, and 30%, respectively. Compared with people who do not burn, those reporting severe sunburn after 1 hr of sun exposure reported more use of sunscreens (odds ratio [OR] = 2.4, 95% confidence interval [CI] 2.0, 2.9), shade (OR = 1.8, 95% CI 1.5, 2.1), and protective clothing (OR = 2.2, 95% CI 1.9, 2.7). Other factors associated with practicing protection behaviors included a personal history of skin cancer, older age, and female sex. CONCLUSIONS: A large percentage of white U.S. adults did not protect themselves from sun exposure. Additional education of the general public and persons at higher risk for skin cancer is needed.


Subject(s)
Health Behavior , Protective Clothing/statistics & numerical data , Skin Neoplasms/prevention & control , Sunburn/prevention & control , Sunlight/adverse effects , Sunscreening Agents/therapeutic use , White People/statistics & numerical data , Adolescent , Adult , Aged , Female , Health Surveys , Humans , Logistic Models , Male , Middle Aged , Skin/radiation effects , Skin Neoplasms/epidemiology , Skin Neoplasms/psychology , Skin Pigmentation/radiation effects , Sunburn/epidemiology , Sunburn/psychology , United States/epidemiology , White People/psychology
16.
Eval Health Prof ; 19(3): 280-91, 1996 Sep.
Article in English | MEDLINE | ID: mdl-10186916

ABSTRACT

The General Accounting Office (GAO) is a legislative branch agency whose mission is to support the oversight role of Congress. Health policy issues have constituted a substantial part of GAO's recent workload. Whereas GAO's work on health has ranged broadly, it has often focused on fraud and abuse in federal programs, particularly Medicare and Medicaid; the lack of meaningful indicators and other information, particularly on outcomes in health programs; access to care, increasingly connected to managed care; quality of care; and issues related to cost control.


Subject(s)
Government Agencies/organization & administration , National Health Programs/organization & administration , Program Evaluation , Cost Control , Fraud , Health Services Accessibility , Humans , Quality of Health Care , United States
17.
J Natl Cancer Inst ; 84(13): 1030-2, 1992 Jul 01.
Article in English | MEDLINE | ID: mdl-1608055

ABSTRACT

BACKGROUND: Cervical cancer mortality rates in the Appalachian population of southeastern Kentucky have been shown to be unusually high. To better understand the high cervical cancer death rate in this area, we developed a population-based cervical disease registry. PURPOSE: This study describes the incidence of cervical dysplasia, carcinoma in situ, and invasive cervical cancer in 1986 and 1987 among White women in a 36-county area of Appalachian Kentucky based on histologic diagnoses. METHODS: We compared average annual age-adjusted incidence rates for carcinoma in situ and invasive cervical cancer in the study area with those for women in the Surveillance, Epidemiology, and End Results (SEER) Program. RESULTS: The incidence rate of invasive cervical cancer for women in the study area (14.9 per 100,000) was nearly twice that for White women in the SEER population (7.8 per 100,000), but it was similar to that for Black women in the SEER population (15.3 per 100,000). The incidence of carcinoma in situ for women in the study population (38.2 per 100,000) was 21% higher than that for White women (31.5 per 100,000) or for Black women (31.2 per 100,000) in the SEER population. The average annual age-adjusted incidence rate for all grades of dysplasia among women in the study population was 194.6 per 100,000. No comparable population-based incidence rates for dysplasia could be identified. CONCLUSIONS: Cervical cancer incidence rates are higher in Appalachian Kentucky than in the SEER population. Poverty appears to be a factor associated with these rates. IMPLICATIONS: Low-density populations such as those in rural Appalachia deserve greater attention in cancer control research. The population-based cervical dysplasia rates reported here may be useful for comparisons in future investigations.


Subject(s)
Uterine Cervical Dysplasia/epidemiology , Uterine Cervical Neoplasms/epidemiology , Appalachian Region/epidemiology , Carcinoma in Situ/epidemiology , Female , Humans , Incidence , Kentucky/epidemiology , Neoplasm Invasiveness , Population Surveillance , Poverty , Rural Health
19.
J Community Health ; 17(2): 97-107, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1602047

ABSTRACT

As a means of developing effective intervention strategies for promoting Pap smear screening, we analyzed data from a population-based women's health survey (N = 603) in a 36-county area in southeastern Kentucky. The cervical cancer mortality rate for white women in this area is one of the highest in the United States. By using selected sociodemographic, health-care utilization, health knowledge, and health behavior variables in age-specific logistic regression models, we discriminated between women who had had a Pap smear within 3.5 years and those who had not. Several variables predicted Pap screening status regardless of the woman's age. Women of all age groups who had not been recently screened had encounters with the medical-care system. A key variable that affected use of screening services was ever use of birth control pills. The main differences between the three age groups were as follows: the 18-44 age group was less likely to see a private physician and less likely to seek medical care of any type, except for care related to pregnancy; only the 45-59 age group believed that cost of medical care was a problem; and only for the 60 or older age group were socioeconomic variables associated with not having recently had a Pap test.


Subject(s)
Papanicolaou Test , Uterine Cervical Neoplasms/diagnosis , Vaginal Smears/statistics & numerical data , Adult , Age Factors , Costs and Cost Analysis , Demography , Female , Health Behavior , Health Services/statistics & numerical data , Humans , Kentucky , Middle Aged , Socioeconomic Factors , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/prevention & control , Vaginal Smears/economics
20.
Acta Cytol ; 33(4): 460-2, 1989.
Article in English | MEDLINE | ID: mdl-2546348

ABSTRACT

Cervical cancer screening and demonstration projects to identify barriers to optimal screening are discussed. Interview surveys showed that older women and women in low-income groups tended to have lower rates of Papanicolaou smear screening. Data produced by demonstration projects established by the Centers for Disease Control in collaboration with state and local authorities and private institutions will be used to design and implement strategies for increasing screening levels to further reduce cervical cancer mortality.


Subject(s)
Health Services Accessibility/trends , Mass Screening/trends , Uterine Cervical Neoplasms/prevention & control , Women's Health Services/trends , Age Factors , Attitude to Health , Centers for Disease Control and Prevention, U.S. , Female , Humans , Papanicolaou Test , Pilot Projects , Socioeconomic Factors , United States , Uterine Cervical Neoplasms/mortality , Vaginal Smears/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...